prepared in collaboration with the WHO Collaborating Centre for International Drug Monitoring
The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of “drug information officers” and other sources such as specialized bulletins and journals, as well as partners in WHO. Information on adverse drug reactions is provided by the WHO Collaborating Centre for International Drug Monitoring. The information is produced in the form of résumés in English full texts of which may be obtained on request from:
Quality Assurance and Safety: Medicines, EDP-HTP,
World Health Organization
1211 Geneva 27
Switzerland
E-mail address: <mailto:qsm@who.int>
Fax: +41 22 791 4730.
Further information on adverse reactions may be obtained from:
WHO Collaborating Centre for International Drug Monitoring
Stora Torget 3
S-753 20 Uppsala
Sweden
Tel: 46-18-65.60.60
Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.org
Internet: http://www.who-umc.org
Loading...
